cysteine and Fetal Death

cysteine has been researched along with Fetal Death in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bazer, FW; Cudd, TA; Datta, S; Keisler, DH; Lassala, A; Satterfield, MC; Spencer, TE; Wu, G1
Górniak, SL; Guerra, JL; Medeiros, RM; Soto-Blanco, B1
Ashby, R; Davis, L; Dewhurst, BB; Espinal, R; Penn, RN; Upshall, DG1
Constantinou, CD; Pack, M; Prockop, DJ; Young, SB1
Constantinou, CD; Nielsen, KB; Prockop, DJ1
Costin, G; Oeriu, I; Otel, V1

Other Studies

6 other study(ies) available for cysteine and Fetal Death

ArticleYear
Parenteral administration of L-arginine enhances fetal survival and growth in sheep carrying multiple fetuses.
    The Journal of nutrition, 2011, Volume: 141, Issue:5

    Topics: 3-Hydroxybutyric Acid; Ammonia; Animals; Arginine; Birth Weight; Body Weight; Cysteine; Female; Fetal Death; Fetal Growth Retardation; Injections, Intravenous; Ornithine; Pregnancy; Pregnancy Outcome; Pregnancy, Multiple; Proline; Random Allocation; Sheep, Domestic

2011
Lack of protective action of cysteine against the fetotoxic effect of monocrotaline.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2001, Volume: 39, Issue:7

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Body Weight; Creatinine; Cysteine; Eating; Female; Fetal Death; Fetus; Male; Monocrotaline; Organ Size; Plant Extracts; Poisoning; Pregnancy; Rats; Rats, Wistar; Treatment Failure; Urea

2001
Aspects of the teratology of cyclophosphamide (NSC-26271).
    Cancer treatment reports, 1976, Volume: 60, Issue:4

    Topics: Abnormalities, Drug-Induced; Alkylation; Animals; Chemical Phenomena; Chemistry; Chlorambucil; Cyclophosphamide; Cysteine; Dose-Response Relationship, Drug; Female; Fetal Death; Gestational Age; Glutathione; Kinetics; Pregnancy; Rats; Teratogens

1976
Phenotypic heterogeneity in osteogenesis imperfecta: the mildly affected mother of a proband with a lethal variant has the same mutation substituting cysteine for alpha 1-glycine 904 in a type I procollagen gene (COL1A1).
    American journal of human genetics, 1990, Volume: 47, Issue:4

    Topics: Alleles; Base Sequence; Blotting, Southern; Cysteine; DNA; DNA Mutational Analysis; Female; Fetal Death; Fibroblasts; Genes, Lethal; Glycine; Humans; Leukocyte Count; Male; Molecular Sequence Data; Mosaicism; Mutation; Osteogenesis Imperfecta; Pedigree; Polymerase Chain Reaction; Procollagen; Protein Processing, Post-Translational

1990
A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable typ
    The Journal of clinical investigation, 1989, Volume: 83, Issue:2

    Topics: Base Sequence; Cysteine; Female; Fetal Death; Genes, Lethal; Glycine; Humans; Infant, Newborn; Molecular Sequence Data; Mutation; Osteogenesis Imperfecta; Peptide Mapping; Pregnancy; Procollagen

1989
The use of folcysteine for the control of embryo mortality in pigs. II. Results of large-scale experiments.
    Zentralblatt fur Veterinarmedizin. Reihe A, 1972, Volume: 19, Issue:9

    Topics: Animals; Cysteine; Female; Fetal Death; Folic Acid; Pregnancy; Swine; Swine Diseases

1972